TETRAHYDROBENZO[a]XANTHEN-11-ONES
1801
temperature. The precipitate formed was collected by filtration at pump, washed well
with water–ethanol (1:1, v=v), and dried. The crude product was recrystallized from
ethanol to yield pure 12-aryl-8,9,10,12-tetrahydrobenzo[a]xanthene-11-one deriva-
tives. The product was identified by mp, IR, NMR, and mass spectra.
Preparation of Compounds 1a–q Under MW Conditions (Method B)
In a 10-mL vial, aldehyde (1.0 mmol), b-naphthol (1.0 mmol), and dimedone or
1,3-cyclohexanedione (1.2 mmol) were mixed thoroughly and p-TSA (2 mol%) was
added. The vial was sealed with a cap containing a septum. The loaded vial was then
placed into the cavity of the microwave reactor and heated at 100 W and 100 ꢁC for
4–6 min (as indicated by thin-layer chromatography, TLC) (Table 1). The mixture
was cooled to room temperature and quenched with 5 mL of water. The precipitate
formed was collected by filtration at pump, washed with water–ethanol (1:1 v=v),
and dried. The crude product was recrystallized from ethanol to yield pure
xanthen-11-one derivative.
Representative Analytical Data
12-(4-Chlorophenyl)-9,9-dimethyl-8,9,10,12-tetrahydrobenzo[a]xanthene-
11-one (1a). White solid, mp 178–180 ꢁC; 1H NMR (400 MHz, CDCl3): d ¼ 7.90 (d,
J ¼ 8.3 Hz, 1H, Ar), 7.76–7.80 (m, 2H, Ar), 7.36–7.46 (m, 2H, Ar), 7.32 (d,
J ¼ 8.9 Hz, 1H, Ar), 7.26–7.28 (m, 2H, Ar), 7.12–7.15 (m, 2H, Ar), 5.67 (s, 1H,
CH), 2.56 (s, 2H, CH2), 2.31 (d, J ¼ 16.3 Hz, 1H, CH), 2.24 (d, J ¼ 16.3 Hz, 1H,
CH), 1.12 (s, 3H, CMe), 0.96 (s, 3H, CMe); IR (nmax cmꢂ1) (KBr): 2956, 1648,
1596, 1374, 1224, 1185; MS (ESI): m=z calc. for C25H21ClO2, 388; found (%) ¼ 388
[(M)þ, 90], 390 [32].
12-(4-Bromophenyl)-9,9-dimethyl-8,9,10,12-tetrahydrobenzo[a]xanthene-
11-one (1b). White solid, mp 183–184 ꢁC; 1H NMR (400 MHz, CDCl3): d ¼ 7.89 (d,
J ¼ 8.3 Hz, 1H, Ar), 7.76–7.80 (m, 2H, Ar), 7.38–7.45 (m, 2H, Ar), 7.26–7.33 (m, 3H,
Ar), 7.20–7.23 (m, 2H, Ar), 5.66 (s, 1H, CH), 2.56 (s, 2H, CH2), 2.31 (d, J ¼ 16.3 Hz,
1H, CH), 2.24 (d, J ¼ 16.3 Hz, 1H, CH), 1.12 (s, 3H, CMe), 0.96 (s, 3H, CMe); 13C
NMR (300 MHz, CDCl3): d ¼ 196.8, 164.0, 147.7, 143.7, 131.5, 131.3, 131.2, 130.1,
129.1, 128.5, 127.1, 125.0, 123.4, 120.1, 117.0, 116.9, 113.7, 50.8, 41.4, 34.2, 32.2,
29.3, 27.1; IR (nmax cmꢂ1) (KBr): 2955, 1652, 1596, 1373, 1228, 1185; MS
(FAB): m=z calc. for C25H21BrO2, 432; found (%) ¼ 433 [(M þ H)þ, 88], 435
[(M þ 2 þ H)þ, 90].
9,9-Dimethyl-12-(4-methylphenyl)-8,9,10,12-tetrahydrobenzo[a]xanthene-
1
11-one (1e). White solid, mp 176–178 ꢁC; H NMR (400 MHz, CDCl3): d ¼ 8.0 (d,
J ¼ 8.4 Hz, 1H, Ar), 7.33–7.77 (m, 2H, Ar), 7.40–7.44 (m, 1H, Ar), 7.32–7.37 (m, 2H,
Ar), 7.20–7.30 (m, 2H, Ar), 6.96 (d, J ¼ 8.0 Hz, 2H, Ar), 5.66 (s, 1H, CH), 2.54 (s,
2H, CH2), 2.30 (d, J ¼ 16.2 Hz, 1H, CH), 2.23 (d, J ¼ 16.2 Hz, 1H, CH), 2.19 (s,
3H, CH3), 1.10 (s, 3H, CMe), 0.98 (s, 3H, CMe); 13C NMR (300 MHz, CDCl3):
d ¼ 196.8, 163.7, 147.7, 141.8, 135.6, 131.5, 131.4, 128.9, 128.6, 128.3, 128.2, 126.9,
124.8, 123.6, 117.9, 117.0,114.4, 50.9, 41.4, 34.2, 32.2, 29.2, 27.2, 20.9; IR